RANGEL PAMPLONA PIZARRO PINTO, José Gaspar, Natalie M. HENDRIKSE, Jan ŠTOURAČ, Jiří DAMBORSKÝ and David BEDNÁŘ. Virtual screening of potential anticancer drugs based on microbial products. Seminars in Cancer Biology. London: Academic Press Ltd.-Elsevier Science Ltd., 2022, vol. 86, November 2022, p. 1207-1217. ISSN 1044-579X. Available from: https://dx.doi.org/10.1016/j.semcancer.2021.07.012.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Virtual screening of potential anticancer drugs based on microbial products
Authors RANGEL PAMPLONA PIZARRO PINTO, José Gaspar (76 Brazil, belonging to the institution), Natalie M. HENDRIKSE, Jan ŠTOURAČ (203 Czech Republic, belonging to the institution), Jiří DAMBORSKÝ (203 Czech Republic, guarantor, belonging to the institution) and David BEDNÁŘ (203 Czech Republic, belonging to the institution).
Edition Seminars in Cancer Biology, London, Academic Press Ltd.-Elsevier Science Ltd. 2022, 1044-579X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 14.500
RIV identification code RIV/00216224:14310/22:00127621
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.semcancer.2021.07.012
UT WoS 000882850000005
Keywords in English Databases; Microbial products; Virtual screening; Web tools; PredictSNP Onco
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Michaela Hylsová, Ph.D., učo 211937. Changed: 9/3/2023 19:58.
Abstract
The development of microbial products for cancer treatment has been in the spotlight in recent years. In order to accelerate the lengthy and expensive drug development process, in silico screening tools are systematically employed, especially during the initial discovery phase. Moreover, considering the steadily increasing number of molecules approved by authorities for commercial use, there is a demand for faster methods to repurpose such drugs. Here we present a review on virtual screening web tools, such as publicly available databases of molecular targets and libraries of ligands, with the aim to facilitate the discovery of potential anticancer drugs based on microbial products. We provide an entry-level step-by-step description of the workflow for virtual screening of microbial metabolites with known protein targets, as well as two practical examples using freely available web tools. The first case presents a virtual screening study of drugs developed from microbial products using Caver Web, a web tool that performs docking along a tunnel. The second case comprises a comparative analysis between a wild type isocitrate dehydrogenase 1 and a mutant that results in cancer, using the recently developed web tool PredictSNPOnco. In summary, this review provides the basic and essential background information necessary for virtual screening experiments, which may accelerate the discovery of novel anticancer drugs.
Links
EF17_043/0009632, research and development projectName: CETOCOEN Excellence
LM2015047, research and development projectName: Česká národní infrastruktura pro biologická data (Acronym: ELIXIR-CZ)
Investor: Ministry of Education, Youth and Sports of the CR, Czech National Infrastructure for Biological Data
LM2018121, research and development projectName: Výzkumná infrastruktura RECETOX (Acronym: RECETOX RI)
Investor: Ministry of Education, Youth and Sports of the CR, RECETOX RI
LM2018140, research and development projectName: e-Infrastruktura CZ (Acronym: e-INFRA CZ)
Investor: Ministry of Education, Youth and Sports of the CR
TN01000013, research and development projectName: Personalizovaná medicína - diagnostika a terapie
Investor: Technology Agency of the Czech Republic, Personalized Medicine – Diagnostics and Therapy
857560, interní kód MU
(CEP code: EF17_043/0009632)
Name: CETOCOEN Excellence (Acronym: CETOCOEN Excellence)
Investor: European Union, Spreading excellence and widening participation
PrintDisplayed: 30/8/2024 04:46